Logo image of MDT

MEDTRONIC PLC (MDT) Stock Fundamental Analysis

USA - NYSE:MDT - IE00BTN1Y115 - Common Stock

93.23 USD
-0.9 (-0.96%)
Last: 10/28/2025, 8:07:34 PM
94.35 USD
+1.12 (+1.2%)
After Hours: 10/28/2025, 8:07:34 PM
Fundamental Rating

6

MDT gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 189 industry peers in the Health Care Equipment & Supplies industry. MDT scores excellent on profitability, but there are some minor concerns on its financial health. MDT has a correct valuation and a medium growth rate. MDT also has an excellent dividend rating. These ratings could make MDT a good candidate for dividend investing.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

MDT had positive earnings in the past year.
In the past year MDT had a positive cash flow from operations.
Each year in the past 5 years MDT has been profitable.
Each year in the past 5 years MDT had a positive operating cash flow.
MDT Yearly Net Income VS EBIT VS OCF VS FCFMDT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

1.2 Ratios

MDT has a better Return On Assets (5.12%) than 82.54% of its industry peers.
Looking at the Return On Equity, with a value of 9.73%, MDT belongs to the top of the industry, outperforming 85.19% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 6.74%, MDT belongs to the top of the industry, outperforming 82.01% of the companies in the same industry.
MDT had an Average Return On Invested Capital over the past 3 years of 6.35%. This is below the industry average of 9.01%.
The 3 year average ROIC (6.35%) for MDT is below the current ROIC(6.74%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 5.12%
ROE 9.73%
ROIC 6.74%
ROA(3y)4.43%
ROA(5y)4.54%
ROE(3y)8.11%
ROE(5y)8.19%
ROIC(3y)6.35%
ROIC(5y)6.24%
MDT Yearly ROA, ROE, ROICMDT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8

1.3 Margins

MDT has a Profit Margin of 13.63%. This is amongst the best in the industry. MDT outperforms 92.06% of its industry peers.
In the last couple of years the Profit Margin of MDT has declined.
MDT has a better Operating Margin (19.57%) than 92.59% of its industry peers.
In the last couple of years the Operating Margin of MDT has remained more or less at the same level.
The Gross Margin of MDT (65.38%) is better than 70.37% of its industry peers.
MDT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 19.57%
PM (TTM) 13.63%
GM 65.38%
OM growth 3Y-3.47%
OM growth 5Y0.37%
PM growth 3Y-4.39%
PM growth 5Y-3.44%
GM growth 3Y-1.55%
GM growth 5Y-0.76%
MDT Yearly Profit, Operating, Gross MarginsMDT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so MDT is destroying value.
The number of shares outstanding for MDT has been reduced compared to 1 year ago.
The number of shares outstanding for MDT has been reduced compared to 5 years ago.
MDT has a worse debt/assets ratio than last year.
MDT Yearly Shares OutstandingMDT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B
MDT Yearly Total Debt VS Total AssetsMDT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B 100B

2.2 Solvency

MDT has an Altman-Z score of 2.94. This is not the best score and indicates that MDT is in the grey zone with still only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 2.94, MDT is doing good in the industry, outperforming 66.67% of the companies in the same industry.
MDT has a debt to FCF ratio of 5.39. This is a neutral value as MDT would need 5.39 years to pay back of all of its debts.
MDT's Debt to FCF ratio of 5.39 is fine compared to the rest of the industry. MDT outperforms 79.37% of its industry peers.
A Debt/Equity ratio of 0.55 indicates that MDT is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.55, MDT is doing worse than 61.38% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF 5.39
Altman-Z 2.94
ROIC/WACC0.99
WACC6.8%
MDT Yearly LT Debt VS Equity VS FCFMDT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B 50B

2.3 Liquidity

A Current Ratio of 2.01 indicates that MDT has no problem at all paying its short term obligations.
MDT's Current ratio of 2.01 is on the low side compared to the rest of the industry. MDT is outperformed by 64.02% of its industry peers.
MDT has a Quick Ratio of 1.50. This is a normal value and indicates that MDT is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.50, MDT perfoms like the industry average, outperforming 40.74% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.01
Quick Ratio 1.5
MDT Yearly Current Assets VS Current LiabilitesMDT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

4

3. Growth

3.1 Past

MDT shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 5.53%.
The Earnings Per Share has been growing slightly by 3.68% on average over the past years.
Looking at the last year, MDT shows a small growth in Revenue. The Revenue has grown by 4.98% in the last year.
MDT shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.01% yearly.
EPS 1Y (TTM)5.53%
EPS 3Y-0.72%
EPS 5Y3.68%
EPS Q2Q%2.44%
Revenue 1Y (TTM)4.98%
Revenue growth 3Y1.91%
Revenue growth 5Y3.01%
Sales Q2Q%6.68%

3.2 Future

Based on estimates for the next years, MDT will show a small growth in Earnings Per Share. The EPS will grow by 6.47% on average per year.
MDT is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.37% yearly.
EPS Next Y3.31%
EPS Next 2Y5.62%
EPS Next 3Y6.2%
EPS Next 5Y6.47%
Revenue Next Year7.02%
Revenue Next 2Y6.24%
Revenue Next 3Y5.84%
Revenue Next 5Y5.37%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
MDT Yearly Revenue VS EstimatesMDT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10B 20B 30B 40B
MDT Yearly EPS VS EstimatesMDT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 16.86, which indicates a correct valuation of MDT.
Based on the Price/Earnings ratio, MDT is valued cheaply inside the industry as 83.60% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 26.83, MDT is valued a bit cheaper.
A Price/Forward Earnings ratio of 15.19 indicates a correct valuation of MDT.
Based on the Price/Forward Earnings ratio, MDT is valued cheaply inside the industry as 86.24% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.88, MDT is valued a bit cheaper.
Industry RankSector Rank
PE 16.86
Fwd PE 15.19
MDT Price Earnings VS Forward Price EarningsMDT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, MDT is valued cheaply inside the industry as 80.95% of the companies are valued more expensively.
MDT's Price/Free Cash Flow ratio is rather cheap when compared to the industry. MDT is cheaper than 84.13% of the companies in the same industry.
Industry RankSector Rank
P/FCF 22.55
EV/EBITDA 13.94
MDT Per share dataMDT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The excellent profitability rating of MDT may justify a higher PE ratio.
PEG (NY)5.09
PEG (5Y)4.58
EPS Next 2Y5.62%
EPS Next 3Y6.2%

7

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 3.01%, MDT has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 1.79, MDT pays a better dividend. On top of this MDT pays more dividend than 98.41% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.30, MDT pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 3.01%

5.2 History

The dividend of MDT has a limited annual growth rate of 5.10%.
MDT has paid a dividend for at least 10 years, which is a reliable track record.
MDT has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)5.1%
Div Incr Years11
Div Non Decr Years11
MDT Yearly Dividends per shareMDT Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

MDT pays out 77.27% of its income as dividend. This is not a sustainable payout ratio.
The dividend of MDT is growing, but earnings are growing more, so the dividend growth is sustainable.
DP77.27%
EPS Next 2Y5.62%
EPS Next 3Y6.2%
MDT Yearly Income VS Free CF VS DividendMDT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B
MDT Dividend Payout.MDT Dividend Payout, showing the Payout Ratio.MDT Dividend Payout.PayoutRetained Earnings

MEDTRONIC PLC

NYSE:MDT (10/28/2025, 8:07:34 PM)

After market: 94.35 +1.12 (+1.2%)

93.23

-0.9 (-0.96%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)08-19 2025-08-19/bmo
Earnings (Next)11-18 2025-11-18/bmo
Inst Owners87.1%
Inst Owner Change-0.1%
Ins Owners0.29%
Ins Owner Change5.53%
Market Cap119.59B
Revenue(TTM)34.20B
Net Income(TTM)4.66B
Analysts73.33
Price Target100.56 (7.86%)
Short Float %1.17%
Short Ratio2.08
Dividend
Industry RankSector Rank
Dividend Yield 3.01%
Yearly Dividend2.77
Dividend Growth(5Y)5.1%
DP77.27%
Div Incr Years11
Div Non Decr Years11
Ex-Date09-26 2025-09-26 (0.71)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1.54%
Min EPS beat(2)1.49%
Max EPS beat(2)1.59%
EPS beat(4)3
Avg EPS beat(4)1.05%
Min EPS beat(4)-0.08%
Max EPS beat(4)1.59%
EPS beat(8)6
Avg EPS beat(8)1.56%
EPS beat(12)9
Avg EPS beat(12)1.82%
EPS beat(16)10
Avg EPS beat(16)1.17%
Revenue beat(2)2
Avg Revenue beat(2)0.54%
Min Revenue beat(2)0.17%
Max Revenue beat(2)0.91%
Revenue beat(4)3
Avg Revenue beat(4)0.07%
Min Revenue beat(4)-1.38%
Max Revenue beat(4)0.91%
Revenue beat(8)6
Avg Revenue beat(8)0.26%
Revenue beat(12)9
Avg Revenue beat(12)0.38%
Revenue beat(16)10
Avg Revenue beat(16)-0.26%
PT rev (1m)0%
PT rev (3m)2.23%
EPS NQ rev (1m)-0.01%
EPS NQ rev (3m)-0.71%
EPS NY rev (1m)-0.03%
EPS NY rev (3m)1.35%
Revenue NQ rev (1m)0.01%
Revenue NQ rev (3m)1.43%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.55%
Valuation
Industry RankSector Rank
PE 16.86
Fwd PE 15.19
P/S 3.5
P/FCF 22.55
P/OCF 16.73
P/B 2.5
P/tB N/A
EV/EBITDA 13.94
EPS(TTM)5.53
EY5.93%
EPS(NY)6.14
Fwd EY6.58%
FCF(TTM)4.13
FCFY4.43%
OCF(TTM)5.57
OCFY5.98%
SpS26.66
BVpS37.34
TBVpS-4.16
PEG (NY)5.09
PEG (5Y)4.58
Graham Number68.16
Profitability
Industry RankSector Rank
ROA 5.12%
ROE 9.73%
ROCE 8.43%
ROIC 6.74%
ROICexc 7.5%
ROICexgc 29.59%
OM 19.57%
PM (TTM) 13.63%
GM 65.38%
FCFM 15.51%
ROA(3y)4.43%
ROA(5y)4.54%
ROE(3y)8.11%
ROE(5y)8.19%
ROIC(3y)6.35%
ROIC(5y)6.24%
ROICexc(3y)7.09%
ROICexc(5y)7.05%
ROICexgc(3y)29.85%
ROICexgc(5y)33.32%
ROCE(3y)7.94%
ROCE(5y)7.8%
ROICexgc growth 3Y-11.61%
ROICexgc growth 5Y-5.52%
ROICexc growth 3Y-2.49%
ROICexc growth 5Y3.26%
OM growth 3Y-3.47%
OM growth 5Y0.37%
PM growth 3Y-4.39%
PM growth 5Y-3.44%
GM growth 3Y-1.55%
GM growth 5Y-0.76%
F-Score7
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF 5.39
Debt/EBITDA 2.72
Cap/Depr 62.54%
Cap/Sales 5.39%
Interest Coverage 9.24
Cash Conversion 74.13%
Profit Quality 113.8%
Current Ratio 2.01
Quick Ratio 1.5
Altman-Z 2.94
F-Score7
WACC6.8%
ROIC/WACC0.99
Cap/Depr(3y)59.68%
Cap/Depr(5y)55.94%
Cap/Sales(3y)5.04%
Cap/Sales(5y)4.79%
Profit Quality(3y)124.85%
Profit Quality(5y)125.74%
High Growth Momentum
Growth
EPS 1Y (TTM)5.53%
EPS 3Y-0.72%
EPS 5Y3.68%
EPS Q2Q%2.44%
EPS Next Y3.31%
EPS Next 2Y5.62%
EPS Next 3Y6.2%
EPS Next 5Y6.47%
Revenue 1Y (TTM)4.98%
Revenue growth 3Y1.91%
Revenue growth 5Y3.01%
Sales Q2Q%6.68%
Revenue Next Year7.02%
Revenue Next 2Y6.24%
Revenue Next 3Y5.84%
Revenue Next 5Y5.37%
EBIT growth 1Y8.97%
EBIT growth 3Y-1.62%
EBIT growth 5Y3.4%
EBIT Next Year19.44%
EBIT Next 3Y10.76%
EBIT Next 5Y9.23%
FCF growth 1Y19.33%
FCF growth 3Y-4.64%
FCF growth 5Y-2.95%
OCF growth 1Y22.55%
OCF growth 3Y-1.39%
OCF growth 5Y-0.53%

MEDTRONIC PLC / MDT FAQ

What is the ChartMill fundamental rating of MEDTRONIC PLC (MDT) stock?

ChartMill assigns a fundamental rating of 6 / 10 to MDT.


Can you provide the valuation status for MEDTRONIC PLC?

ChartMill assigns a valuation rating of 6 / 10 to MEDTRONIC PLC (MDT). This can be considered as Fairly Valued.


How profitable is MEDTRONIC PLC (MDT) stock?

MEDTRONIC PLC (MDT) has a profitability rating of 8 / 10.


What are the PE and PB ratios of MEDTRONIC PLC (MDT) stock?

The Price/Earnings (PE) ratio for MEDTRONIC PLC (MDT) is 16.86 and the Price/Book (PB) ratio is 2.5.


Can you provide the financial health for MDT stock?

The financial health rating of MEDTRONIC PLC (MDT) is 5 / 10.